Susan G. Komen has announced the recipients of the 2015 Brinker Awards for Scientific Distinction, which honors leading scientists who have made the most significant advances in breast cancer research and medicine. The 2015 recipients of the Brinker Awards for Scientific Distinction are Myles A. Brown, MD, of Dana-Farber Cancer Institute, Boston, and Martine Piccart, MD, PhD, of Jules Bordet Institute, Brussels. Drs. Brown and Piccart will present their award lecture at the upcoming San Antonio Breast Cancer Symposium, on December 9, 2015.
Myles Brown, MD
Dr. Brown received the Brinker Award for Scientific Distinction in Basic Science for his significant contributions to breast cancer research, which have been essential in understanding the role of steroid hormones, like estrogen and progesterone, and their receptors in normal physiology and the progression of breast cancer. His work has resulted in critical insights into the factors and signaling pathways that regulate steroid hormone action and is helping to lay the foundation for the development and clinical use of cancer drugs that target these proteins. Dr. Brown will present his lecture, “Hacking the Hormone Code in ER+ Breast Cancer,” in San Antonio.
Martine Piccart, MD, PhD
Dr. Piccart received the Brinker Award for Scientific Distinction in Clinical Research for her seminal contributions in improving the treatment of breast cancer, which have helped to shape the standard of care for breast cancer patients globally. Dr. Piccart has devoted her career to improving breast cancer patient care and expanding the understanding of breast cancer biology. She has led a wide range of translational clinical trials testing new therapeutic agents for the treatment of breast cancer—trials that have had a lasting impact on patient outcomes. Dr. Piccart will present her lecture, “Lessons Learned From an Expedition Exploring the World of HER2-Positive Breast Cancer,” in San Antonio.
Watch next month’s issues of The ASCO Post for comprehensive coverage of the San Antonio Breast Cancer Symposium. ■
